← Back to Clinical Trials
Recruiting NCT04880096

NCT04880096 Cohort of Chronic Pain Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04880096
Status Recruiting
Phase
Sponsor University Hospital, Clermont-Ferrand
Condition Chronic Pain
Study Type OBSERVATIONAL
Enrollment 5,000 participants
Start Date 2021-09-14
Primary Completion 2026-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
eDOL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 5,000 participants in total. It began in 2021-09-14 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Chronic pain affects approximately 20% of adults, 50% of the elderly population and over 1.5 billion people worldwide. Societal and economic issues are also crucial, as 60% of people with pain are less able or unable to work and 20% say they have lost their jobs because of pain. The overall cost of chronic pain is estimated at around 300 billion euros in the EU. Unfortunately, current treatments for chronic pain have limited effectiveness and important adverse effects. Pain clinics, which support the most complex and refractory cases of chronic pain, as well as general practitioners and patients expect improvements, both in terms of therapeutic efficacy and organization of care. In order to allow the characterization and a personalized follow-up of chronic pain patients, we have created e-DOL, a smartphone application for patients and a web platform for healthcare professionals in pain clinics. The purpose of this study is to create an e-cohort for the research, and characterization and follow-up of chronic pain patients.

Eligibility Criteria

Inclusion Criteria: * All patients with chronic pain * patients equipped and regular users of a smartphone * Non-opposition to participation in the study Exclusion Criteria: * Patient unable to understand or answer questionnaires

Contact & Investigator

Central Contact

Lise Laclautre

✉ promo_interne_drci@chu-clermontferrand.fr

📞 04 73 75 11 95

Frequently Asked Questions

Who can join the NCT04880096 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04880096 currently recruiting?

Yes, NCT04880096 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.

Where is the NCT04880096 trial being conducted?

This trial is being conducted at Clermont-Ferrand, France, Clermont-Ferrand, France, Boulogne-Billancourt, France, Paris, France and 11 additional locations.

Who is sponsoring the NCT04880096 clinical trial?

NCT04880096 is sponsored by University Hospital, Clermont-Ferrand. The trial plans to enroll 5,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology